Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 150

1.

Approaches to Perineural, Lymphovascular, and Single-Cell Disease.

Collins MK, Behshad R, Maloney M, Pugliano-Mauro M.

Dermatol Surg. 2019 Dec;45 Suppl 2:S118-S128. doi: 10.1097/DSS.0000000000002259.

PMID:
31764297
2.

Use of Heterologous Vesiculovirus G Proteins Circumvents the Humoral Anti-envelope Immunity in Lentivector-Based In Vivo Gene Delivery.

Munis AM, Mattiuzzo G, Bentley EM, Collins MK, Eyles JE, Takeuchi Y.

Mol Ther Nucleic Acids. 2019 Sep 6;17:126-137. doi: 10.1016/j.omtn.2019.05.010. Epub 2019 May 28.

3.

Author Correction: TMEM16F activation by Ca2+ triggers plasma membrane expansion and directs PD-1 trafficking.

Bricogne C, Fine M, Pereira PM, Sung J, Tijani M, Wang Y, Henriques R, Collins MK, Hilgemann DW.

Sci Rep. 2019 May 17;9(1):7705. doi: 10.1038/s41598-019-43808-0.

4.

Human Papillomavirus Vaccination Rates of Military and Civilian Male Respondents to the Behavioral Risk Factors Surveillance System Between 2013 and 2015.

Collins MK, Tarney C, Craig ER, Beltran T, Han J.

Mil Med. 2019 Mar 1;184(Suppl 1):121-125. doi: 10.1093/milmed/usy376.

PMID:
30901454
5.

TMEM16F activation by Ca2+ triggers plasma membrane expansion and directs PD-1 trafficking.

Bricogne C, Fine M, Pereira PM, Sung J, Tijani M, Wang Y, Henriques R, Collins MK, Hilgemann DW.

Sci Rep. 2019 Jan 24;9(1):619. doi: 10.1038/s41598-018-37056-x. Erratum in: Sci Rep. 2019 May 17;9(1):7705.

6.

Characterization of Antibody Interactions with the G Protein of Vesicular Stomatitis Virus Indiana Strain and Other Vesiculovirus G Proteins.

Munis AM, Tijani M, Hassall M, Mattiuzzo G, Collins MK, Takeuchi Y.

J Virol. 2018 Nov 12;92(23). pii: e00900-18. doi: 10.1128/JVI.00900-18. Print 2018 Dec 1.

7.

TLR9 and IL-1R1 Promote Mobilization of Pulmonary Dendritic Cells during Beryllium Sensitization.

Wade MF, Collins MK, Richards D, Mack DG, Martin AK, Dinarello CA, Fontenot AP, McKee AS.

J Immunol. 2018 Oct 15;201(8):2232-2243. doi: 10.4049/jimmunol.1800303. Epub 2018 Sep 5.

8.

Lentivector Producer Cell Lines with Stably Expressed Vesiculovirus Envelopes.

Tijani M, Munis AM, Perry C, Sanber K, Ferraresso M, Mukhopadhyay T, Themis M, Nisoli I, Mattiuzzo G, Collins MK, Takeuchi Y.

Mol Ther Methods Clin Dev. 2018 Aug 7;10:303-312. doi: 10.1016/j.omtm.2018.07.013. eCollection 2018 Sep 21.

9.

Novel application of virtual reality in patient engagement for deep brain stimulation: A pilot study.

Collins MK, Ding VY, Ball RL, Dolce DL, Henderson JM, Halpern CH.

Brain Stimul. 2018 Jul - Aug;11(4):935-937. doi: 10.1016/j.brs.2018.03.012. Epub 2018 Mar 15. No abstract available.

PMID:
29631869
10.

Postoperative Concurrent Chemoradiotherapy Versus Postoperative Radiotherapy in High-Risk Cutaneous Squamous Cell Carcinoma of the Head and Neck: The Randomized Phase III TROG 05.01 Trial.

Porceddu SV, Bressel M, Poulsen MG, Stoneley A, Veness MJ, Kenny LM, Wratten C, Corry J, Cooper S, Fogarty GB, Collins M, Collins MK, Macann AMJ, Milross CG, Penniment MG, Liu HY, King MT, Panizza BJ, Rischin D.

J Clin Oncol. 2018 May 1;36(13):1275-1283. doi: 10.1200/JCO.2017.77.0941. Epub 2018 Mar 14.

PMID:
29537906
11.

Cutaneous squamous cell carcinoma with epidermodysplasia verruciformis-like features in a patient with Schimke immune-osseous dysplasia.

Collins MK, Peters K, English JC 3rd, Rady P, Tyring S, Jedrych J.

J Cutan Pathol. 2018 Jun;45(6):465-467. doi: 10.1111/cup.13139. Epub 2018 Apr 3. No abstract available.

PMID:
29498428
12.

IKKγ-Mimetic Peptides Block the Resistance to Apoptosis Associated with Kaposi's Sarcoma-Associated Herpesvirus Infection.

Briggs LC, Chan AWE, Davis CA, Whitelock N, Hotiana HA, Baratchian M, Bagnéris C, Selwood DL, Collins MK, Barrett TE.

J Virol. 2017 Nov 14;91(23). pii: e01170-17. doi: 10.1128/JVI.01170-17. Print 2017 Dec 1.

13.

Multifocal primary cutaneous nodular amyloidosis.

Matsumoto ME, Collins MK, Raptis A, Jedrych J, Patton T.

Dermatol Online J. 2017 May 15;23(5). pii: 13030/qt9511r6bg. Review.

14.

In Vivo Gene Delivery to Lymph Node Stromal Cells Leads to Transgene-specific CD8+ T Cell Anergy in Mice.

Ciré S, Da Rocha S, Ferrand M, Collins MK, Galy A.

Mol Ther. 2016 Nov;24(11):1965-1973. doi: 10.1038/mt.2016.168. Epub 2016 Aug 26.

15.

Distinct Activation Mechanisms of NF-κB Regulator Inhibitor of NF-κB Kinase (IKK) by Isoforms of the Cell Death Regulator Cellular FLICE-like Inhibitory Protein (cFLIP).

Baratchian M, Davis CA, Shimizu A, Escors D, Bagnéris C, Barrett T, Collins MK.

J Biol Chem. 2016 Apr 1;291(14):7608-20. doi: 10.1074/jbc.M116.718122. Epub 2016 Feb 10.

16.

Human and Murine Tissue-Engineered Colon Exhibit Diverse Neuronal Subtypes and Can Be Populated by Enteric Nervous System Progenitor Cells When Donor Colon Is Aganglionic.

Wieck MM, El-Nachef WN, Hou X, Spurrier RG, Holoyda KA, Schall KA, Mojica SG, Collins MK, Trecartin A, Cheng Z, Frykman PK, Grikscheit TC.

Tissue Eng Part A. 2016 Jan;22(1-2):53-64. doi: 10.1089/ten.TEA.2015.0120. Epub 2015 Oct 28.

17.

Probing the solution structure of IκB kinase (IKK) subunit γ and its interaction with Kaposi sarcoma-associated herpes virus Flice-interacting protein and IKK subunit β by EPR spectroscopy.

Bagnéris C, Rogala KB, Baratchian M, Zamfir V, Kunze MB, Dagless S, Pirker KF, Collins MK, Hall BA, Barrett TE, Kay CW.

J Biol Chem. 2015 Sep 18;290(38):23024. doi: 10.1074/jbc.A114.622928. No abstract available.

18.
19.

Probing the Solution Structure of IκB Kinase (IKK) Subunit γ and Its Interaction with Kaposi Sarcoma-associated Herpes Virus Flice-interacting Protein and IKK Subunit β by EPR Spectroscopy.

Bagnéris C, Rogala KB, Baratchian M, Zamfir V, Kunze MB, Dagless S, Pirker KF, Collins MK, Hall BA, Barrett TE, Kay CW.

J Biol Chem. 2015 Jul 3;290(27):16539-49. doi: 10.1074/jbc.M114.622928. Epub 2015 May 14. Erratum in: J Biol Chem. 2015 Sep 18;290(38):23024.

20.

Construction of stable packaging cell lines for clinical lentiviral vector production.

Sanber KS, Knight SB, Stephen SL, Bailey R, Escors D, Minshull J, Santilli G, Thrasher AJ, Collins MK, Takeuchi Y.

Sci Rep. 2015 Mar 12;5:9021. doi: 10.1038/srep09021.

21.

Hyperbaric oxygen therapy for chronic radiation-induced tissue injuries: Australasia's largest study.

Tahir AR, Westhuyzen J, Dass J, Collins MK, Webb R, Hewitt S, Fon P, McKay M.

Asia Pac J Clin Oncol. 2015 Mar;11(1):68-77. doi: 10.1111/ajco.12289. Epub 2014 Nov 9.

PMID:
25382755
22.

4-1BB ligand activates bystander dendritic cells to enhance immunization in trans.

Macdonald DC, Hotblack A, Akbar S, Britton G, Collins MK, Rosenberg WC.

J Immunol. 2014 Nov 15;193(10):5056-64. doi: 10.4049/jimmunol.1301723. Epub 2014 Oct 10.

23.

Immunization of mice with lentiviral vectors targeted to MHC class II+ cells is due to preferential transduction of dendritic cells in vivo.

Ciré S, Da Rocha S, Yao R, Fisson S, Buchholz CJ, Collins MK, Galy A.

PLoS One. 2014 Jul 24;9(7):e101644. doi: 10.1371/journal.pone.0101644. eCollection 2014.

24.

Screening for melanoma.

Collins MK, Secrest AM, Ferris LK.

Melanoma Res. 2014 Oct;24(5):428-36. doi: 10.1097/CMR.0000000000000104. Review.

PMID:
24999755
25.

Cis-acting pathways selectively enforce the non-immunogenicity of shed placental antigen for maternal CD8 T cells.

Tay CS, Tagliani E, Collins MK, Erlebacher A.

PLoS One. 2013 Dec 31;8(12):e84064. doi: 10.1371/journal.pone.0084064. eCollection 2013.

26.

Compliance with pregnancy prevention measures during isotretinoin therapy.

Collins MK, Moreau JF, Opel D, Swan J, Prevost N, Hastings M, Bimla Schwarz E, Korb Ferris L.

J Am Acad Dermatol. 2014 Jan;70(1):55-9. doi: 10.1016/j.jaad.2013.08.034. Epub 2013 Oct 21.

PMID:
24157382
27.

Novel function for the p38-MK2 signaling pathway in circulating CD1c+ (BDCA-1+) myeloid dendritic cells from healthy donors and advanced cancer patients; inhibition of p38 enhances IL-12 whilst suppressing IL-10.

Franks HA, Wang Q, Lax SJ, Collins MK, Escors D, Patel PM, Jackson AM.

Int J Cancer. 2014 Feb 1;134(3):575-86. doi: 10.1002/ijc.28398. Epub 2013 Sep 13.

28.

Harnessing alveolar macrophages for sustained mucosal T-cell recall confers long-term protection to mice against lethal influenza challenge without clinical disease.

Macdonald DC, Singh H, Whelan MA, Escors D, Arce F, Bottoms SE, Barclay WS, Maini M, Collins MK, Rosenberg WM.

Mucosal Immunol. 2014 Jan;7(1):89-100. doi: 10.1038/mi.2013.27. Epub 2013 May 29.

PMID:
23715172
29.

Lentiviral vector followed by protein immunisation breaks tolerance against the self-antigen Her1 and results in lung cancer immunotherapy.

Alpizar YA, Karwacz K, Arce F, Yglesias Rivera A, Fernández LE, Collins MK, Sánchez Ramírez B.

J Gene Med. 2012 Mar;14(3):151-7. doi: 10.1002/jgm.2606.

PMID:
22262303
30.

Escape from R-peptide deletion in a γ-retrovirus.

Schneider IC, Eckhardt M, Brynza J, Collins MK, Cichutek K, Buchholz CJ.

Virology. 2011 Sep 30;418(2):85-92. doi: 10.1016/j.virol.2011.07.011. Epub 2011 Aug 10.

31.

miR-30b/30d regulation of GalNAc transferases enhances invasion and immunosuppression during metastasis.

Gaziel-Sovran A, Segura MF, Di Micco R, Collins MK, Hanniford D, Vega-Saenz de Miera E, Rakus JF, Dankert JF, Shang S, Kerbel RS, Bhardwaj N, Shao Y, Darvishian F, Zavadil J, Erlebacher A, Mahal LK, Osman I, Hernando E.

Cancer Cell. 2011 Jul 12;20(1):104-18. doi: 10.1016/j.ccr.2011.05.027.

32.

Ten years of progress in vaccination against cancer: the need to counteract cancer evasion by dual targeting in future therapies.

Alpizar YA, Chain B, Collins MK, Greenwood J, Katz D, Stauss HJ, Mitchison NA.

Cancer Immunol Immunother. 2011 Aug;60(8):1127-35. doi: 10.1007/s00262-011-0985-7. Epub 2011 Apr 9. Review.

PMID:
21479639
33.

A lentiviral vector pseudotype suitable for vaccine development.

Lopes L, Dewannieux M, Takeuchi Y, Collins MK.

J Gene Med. 2011 Mar;13(3):181-7. doi: 10.1002/jgm.1553.

PMID:
21394858
34.

Lentiviral vectors targeted to MHC II are effective in immunization.

Ageichik A, Buchholz CJ, Collins MK.

Hum Gene Ther. 2011 Oct;22(10):1249-54. doi: 10.1089/hum.2010.184. Epub 2011 Mar 23.

PMID:
21247346
35.

Lentiviral vectors transduce proliferating dendritic cell precursors leading to persistent antigen presentation and immunization.

Arce F, Rowe HM, Chain B, Lopes L, Collins MK.

Mol Ther. 2009 Sep;17(9):1643-50. doi: 10.1038/mt.2009.149. Epub 2009 Jul 7.

36.

Dendritic cell entrapment within the pregnant uterus inhibits immune surveillance of the maternal/fetal interface in mice.

Collins MK, Tay CS, Erlebacher A.

J Clin Invest. 2009 Jul;119(7):2062-73. doi: 10.1172/JCI38714. Epub 2009 Jun 22.

37.

Single-chain antibodies that target lentiviral vectors to MHC class II on antigen-presenting cells.

Gennari F, Lopes L, Verhoeyen E, Marasco W, Collins MK.

Hum Gene Ther. 2009 Jun;20(6):554-62. doi: 10.1089/hum.2008.189.

PMID:
19260768
38.

Nonintegrating lentivector vaccines stimulate prolonged T-cell and antibody responses and are effective in tumor therapy.

Karwacz K, Mukherjee S, Apolonia L, Blundell MP, Bouma G, Escors D, Collins MK, Thrasher AJ.

J Virol. 2009 Apr;83(7):3094-103. doi: 10.1128/JVI.02519-08. Epub 2009 Jan 28.

39.

Expression of vFLIP in a lentiviral vaccine vector activates NF-{kappa}B, matures dendritic cells, and increases CD8+ T-cell responses.

Rowe HM, Lopes L, Brown N, Efklidou S, Smallie T, Karrar S, Kaye PM, Collins MK.

J Virol. 2009 Feb;83(4):1555-62. doi: 10.1128/JVI.00709-08. Epub 2008 Nov 26.

40.

Insertional gene activation by lentiviral and gammaretroviral vectors.

Bokhoven M, Stephen SL, Knight S, Gevers EF, Robinson IC, Takeuchi Y, Collins MK.

J Virol. 2009 Jan;83(1):283-94. doi: 10.1128/JVI.01865-08. Epub 2008 Oct 22.

41.

Spontaneous heteromerization of gammaretrovirus envelope proteins: a possible novel mechanism of retrovirus restriction.

Dewannieux M, Collins MK.

J Virol. 2008 Oct;82(19):9789-94. doi: 10.1128/JVI.02696-07. Epub 2008 Jul 30.

42.

Lentivector targeting to dendritic cells.

Ageichik A, Collins MK, Dewannieux M.

Mol Ther. 2008 Jun;16(6):1008-9. doi: 10.1038/mt.2008.95. No abstract available.

43.

vFLIP from KSHV inhibits anoikis of primary endothelial cells.

Efklidou S, Bailey R, Field N, Noursadeghi M, Collins MK.

J Cell Sci. 2008 Feb 15;121(Pt 4):450-7. doi: 10.1242/jcs.022343. Epub 2008 Jan 22.

44.

Targeting dendritic cell signaling to regulate the response to immunization.

Escors D, Lopes L, Lin R, Hiscott J, Akira S, Davis RJ, Collins MK.

Blood. 2008 Mar 15;111(6):3050-61. doi: 10.1182/blood-2007-11-122408. Epub 2008 Jan 7.

PMID:
18180378
45.

Immunization with a lentivector that targets tumor antigen expression to dendritic cells induces potent CD8+ and CD4+ T-cell responses.

Lopes L, Dewannieux M, Gileadi U, Bailey R, Ikeda Y, Whittaker C, Collin MP, Cerundolo V, Tomihari M, Ariizumi K, Collins MK.

J Virol. 2008 Jan;82(1):86-95. Epub 2007 Oct 24.

46.

Stable gene transfer to muscle using non-integrating lentiviral vectors.

Apolonia L, Waddington SN, Fernandes C, Ward NJ, Bouma G, Blundell MP, Thrasher AJ, Collins MK, Philpott NJ.

Mol Ther. 2007 Nov;15(11):1947-54. Epub 2007 Aug 14.

47.

Conscience clauses and oral contraceptives: conscientious objection or calculated obstruction?

Collins MK.

Ann Health Law. 2006 Winter;15(1):37-60, table of contents.

PMID:
17552133
48.

Tubulovesicular structures within vesicular stomatitis virus G protein-pseudotyped lentiviral vector preparations carry DNA and stimulate antiviral responses via Toll-like receptor 9.

Pichlmair A, Diebold SS, Gschmeissner S, Takeuchi Y, Ikeda Y, Collins MK, Reis e Sousa C.

J Virol. 2007 Jan;81(2):539-47. Epub 2006 Nov 1.

49.

Cyclosporine increases human immunodeficiency virus type 1 vector transduction of primary mouse cells.

Noser JA, Towers GJ, Sakuma R, Dumont JM, Collins MK, Ikeda Y.

J Virol. 2006 Aug;80(15):7769-74.

50.

Immunization with a lentiviral vector stimulates both CD4 and CD8 T cell responses to an ovalbumin transgene.

Rowe HM, Lopes L, Ikeda Y, Bailey R, Barde I, Zenke M, Chain BM, Collins MK.

Mol Ther. 2006 Feb;13(2):310-9. Epub 2005 Nov 4.

Supplemental Content

Loading ...
Support Center